INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Obalon Therapeutics, Inc. – OBLN

NEW YORK--()--Levi & Korsinsky announces it has commenced an investigation of Obalon Therapeutics, Inc. (NASDAQGM:OBLN) concerning possible violations of federal securities laws. On January 23, 2018, Obalon announced the termination of an underwriting agreement and cancellation of its previously-announced public offering. To obtain additional information, go to:

http://www.zlkdocs.com/OBLN-Info-Request-Form-6401

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
(212) 363-7500, toll-free: (877) 363-5972
jlevi@levikorsinsky.com

Release Summary

Levi & Korsinsky reminds investors it has commenced an investigation of Obalon Therapeutics, Inc.

Contacts

Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
(212) 363-7500, toll-free: (877) 363-5972
jlevi@levikorsinsky.com